- Previous Close
0.7900 - Open
0.7900 - Bid 0.6200 x --
- Ask 0.7900 x --
- Day's Range
0.7900 - 0.7900 - 52 Week Range
0.3000 - 1.6700 - Volume
669 - Avg. Volume
14,517 - Market Cap (intraday)
56.046M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Chosa Oncology AB develops oncology drugs for the treatment of cancer. The company was formerly known as Chosa ApS. Chosa Oncology AB incorporated in 2022 and is based in Lund, Sweden.
www.chosaoncology.comRecent News: CHOSA.ST
View MorePerformance Overview: CHOSA.ST
Trailing total returns as of 11/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CHOSA.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CHOSA.ST
View MoreValuation Measures
Market Cap
56.05M
Enterprise Value
47.27M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
3.13
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-7.4M
Diluted EPS (ttm)
-0.1200
Balance Sheet and Cash Flow
Total Cash (mrq)
11.14M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--